自主功能障碍与肌缩侧面硬化症的疾病进展和生存有关:一项前性的纵向队列研究
Raffaele Dubbioso1, Vincenzo Provitera2, Daniela Pacella3
1Department of Neurosciences, Reproductive Sciences and Odontostomatology, University Federico II of Naples, Via Sergio Pansini, 5, 80131, Naples, Italy. raffaele.dubbioso@unina.it.
Journal of neurology
|June 26, 2023
概括
自主功能障碍在肌缩侧面硬化症 (ALS) 中很常见,并且随着时间的推移而恶化. 增加的自主性症状预测ALS患者的疾病进展速度更快,存活时间更短.
科学领域:
- 神经学 神经学
- 自主神经系统研究 自主神经系统研究
- 肌缩侧面硬化症 (ALS) 研究研究
背景情况:
- 自主性障碍是肌缩侧面硬化症 (ALS) 的常见非运动症状,影响高达75%的患者.
- 以前的研究还没有系统地评估自主症状作为ALS进展的预后指标.
研究的目的:
- 调查自主功能障碍与肌缩侧面硬化症 (ALS) 疾病进展之间的关联.
- 检查自主功能障碍对被诊断为ALS的患者的存活率的影响.
主要方法:
- 一项纵向研究,将新诊断的肌缩性侧面硬化症 (ALS) 患者与健康对照者 (HC) 进行比较.
- 通过问卷评估自主症状,并通过心率变化 (HRV) 评估副交感心血管活动.
- 使用多变量Cox比例危险回归和混合效应线性回归模型进行统计分析.
主要成果:
- 肌缩性侧面硬化症 (ALS) 患者报告的自主症状比健康对照 (HC) 更多,特别是那些带有凸轮发作的患者.
- 自主症状在诊断时存在于68%的患者中,随着时间的推移而增加.
- 较高的自主性症状负担与更快的King's 4阶段进展相关 (HR 1.05;P=.022),尿路投诉预测了更短的生存期 (HR 3.12;P=.018).
- 与HC相比,ALS患者的心率变化 (HRV) 低于ALS患者,并且随着时间的推移而下降,这表明渐进的副交感性低功能的迹象.
结论:
- 自主症状在肌缩侧面硬化症 (ALS) 的诊断时普遍存在,并在纵向上恶化,这表明它们是疾病的内在特征.
- 较大的自主症状负担是ALS的负面预后因素.
- 自主功能障碍与加速疾病进展和减少肌缩侧面硬化症 (ALS) 的存活率有关.
相关概念视频
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Cross-bridge Cycle
117.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.7K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Disorders of the Autonomic Nervous System
720
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
720
Alzheimer's Disease: Overview
530
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
530


